Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

Gsync Pulsar is going to live or die by how well it handles refresh rates that are actually, well, variable. The motion ...

Many projects on these pages do clever things with video. Whether it’s digital or analogue, it’s certain our community can ...

Stripe is a payment service provider that accepts credit cards, digital wallets and many other payment methods. Many, or all, of the products featured on this page are from our advertising partners ...

Researchers say the innovation, known as SmartEM, will speed scanning sevenfold and open the field of connectomics to a ...

Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.

Most planetary systems contain worlds larger than Earth but smaller than Neptune, and the low-density planets around one ...

The software firm has again been recognized as one of the 100 Best Large Places to Work in Chicago by Built In We are ...

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...

Demand for wind energy remains strong despite reduction in incentives. The wind power market will continue its rapid ...

Are you using pimple patches correctly? Dermatologists reveal common mistakes that prevent them from working, including when ...